Site Management/Investigator Payments Featured Articles
-
How AI And Secondary Data Use Are Changing The Way We Do CTAs, Part Two
5/19/2025
Leibowitz Law experts examine how tech developments affect key CTA provisions and provide practical, technology-inspired updates for your clinical trial agreements. Part two covers the secondary use of study data and AI.
-
Refresh Your CTA Strategy With Cybersecurity And EHRs In Mind, Part One
5/19/2025
Leibowitz Law experts examine how tech developments affect key CTA provisions and provide practical, technology-inspired updates for your clinical trial agreements. Part one of this two-part series explores cybersecurity and EHR standards.
-
Are Sites Even Using AI?: How Sponsors And CROs Can Support Uptake
5/16/2025
How much are clinical research sites using AI? And how can sponsors and CROs effectively support sites in doing so? Consultant Maria P. Ladd explains.
-
5 Ways AI Is Changing Clinical Research — And How To Embrace It
5/15/2025
Discover how AI is transforming clinical trials, learn real tools already in use, and get practical guidance for clinical professionals — especially CRAs and site teams — looking to upskill in an AI-enhanced environment.
-
3 Strategies For A Successful Journey Toward Cell And Gene Therapy Commercialization
5/13/2025
CTMC's Amy Hay provides 3 recommendations for teams developing cell and gene therapies, from clinical research through commercialization.
-
The Potential Impact Of U.S. Tariffs On The Biotech Sector: Manufacturing, Funding, And Clinical Trials
5/12/2025
Syner-G Biopharma Group's Raymond Forslund, Ph.D., MBA explores how U.S. tariffs might affect biotech manufacturing, funding, and clinical research.
-
The Risk And Reward Of Clinical Investigators Integrating AI
5/1/2025
Husch Blackwell LLP experts discuss relevant regulatory frameworks and the risks and liabilities of clinical investigators using AI.
-
Run Better Trials By Rewriting The CRA-Site Relationship Playbook
4/29/2025
Senior CRA Bryce Nichols explains how sites can use their CRAs — beyond their monitoring duties — to improve site efficiency, communication, and trial success.
-
Japan's Adoption Of DCTs Is Slow But Steady
4/16/2025
While global momentum for DCTs accelerates, Japanese healthcare institutions face unique structural and operational hurdles to implement remote and digital trial activities.
-
From Tissue Donation To Distribution: Understanding EU Regulatory Requirements In Cell Therapy Clinical Trials
4/14/2025
Understanding how the European Union's Directive 2004/23/EC interacts with GMP — and where its jurisdiction begins and ends — is essential for successful clinical trial planning, compliance, and execution.